For investigators

Information for investigators around trial design, criteria and outcomes.

PROPHESY-2 trial logo

The PROPHESY-2 trial will assess whether prothrombin complex concentrate is superior to fresh frozen plasma with respect to a composite of mortality, organ failure or infection up to and including 90 days from randomisation in adult patients who are actively bleeding within 24 hours of their cardiac surgery.